JP2022523507A5 - - Google Patents
Info
- Publication number
- JP2022523507A5 JP2022523507A5 JP2021544406A JP2021544406A JP2022523507A5 JP 2022523507 A5 JP2022523507 A5 JP 2022523507A5 JP 2021544406 A JP2021544406 A JP 2021544406A JP 2021544406 A JP2021544406 A JP 2021544406A JP 2022523507 A5 JP2022523507 A5 JP 2022523507A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- sequence
- amino acid
- specific binding
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1901305.1 | 2019-01-30 | ||
| GBGB1901305.1A GB201901305D0 (en) | 2019-01-30 | 2019-01-30 | Specific binding molecules |
| PCT/EP2020/052315 WO2020157210A1 (en) | 2019-01-30 | 2020-01-30 | Cd3-specific binding molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523507A JP2022523507A (ja) | 2022-04-25 |
| JP2022523507A5 true JP2022523507A5 (enExample) | 2023-03-10 |
| JP7530904B2 JP7530904B2 (ja) | 2024-08-08 |
Family
ID=65997940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544406A Active JP7530904B2 (ja) | 2019-01-30 | 2020-01-30 | 特異的結合性分子 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12590152B2 (enExample) |
| EP (1) | EP3917959A1 (enExample) |
| JP (1) | JP7530904B2 (enExample) |
| KR (1) | KR20210121141A (enExample) |
| CN (1) | CN113728005B (enExample) |
| AU (1) | AU2020215776A1 (enExample) |
| BR (1) | BR112021014963A2 (enExample) |
| CA (1) | CA3127144A1 (enExample) |
| GB (1) | GB201901305D0 (enExample) |
| IL (1) | IL284926B2 (enExample) |
| MX (1) | MX2021009275A (enExample) |
| WO (1) | WO2020157210A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| CN117964777A (zh) * | 2021-08-26 | 2024-05-03 | 瑅安生物医药（杭州）有限公司 | 一种接近天然分子的多肽融合分子 |
| AU2023222190A1 (en) | 2022-02-20 | 2024-08-29 | Immunocore Limited | Hiv-specific binding molecules and tcr |
| EP4573125A1 (en) | 2022-08-18 | 2025-06-25 | Immunocore Limited | Multi-domain binding molecules |
| WO2024146951A1 (en) | 2023-01-06 | 2024-07-11 | Immunocore Limited | Binding molecules against a prame peptide-hla complex |
| WO2024146936A1 (en) | 2023-01-06 | 2024-07-11 | Immunocore Limited | Binding molecules against a piwil1 peptide-hla complex |
| TW202519257A (zh) * | 2023-08-01 | 2025-05-16 | 英商英美偌科有限公司 | 治療皮膚黑色素瘤之方法 |
| WO2025050404A1 (zh) * | 2023-09-08 | 2025-03-13 | 成都维瑾柏鳌生物医药科技有限公司 | 一种药物组合物及其应用 |
| GB202320012D0 (en) | 2023-12-22 | 2024-02-07 | Immunocore Ltd | Bispecific molecules |
| GB2641580A (en) | 2024-06-07 | 2025-12-10 | T Therapeutics Ltd | Tumour-transforming multispecific proteins |
| WO2026078231A1 (en) | 2024-10-11 | 2026-04-16 | T-Therapeutics Limited | Soluble non-aggregating immune ligand |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US36676A (en) | 1862-10-14 | Improvement in grain-cleaners | ||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| AU7757581A (en) | 1980-11-19 | 1982-05-27 | United Energy Technologies Inc. | Enhanced surface tubing |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| JPS5855530Y2 (ja) | 1981-06-15 | 1983-12-20 | 松下電工株式会社 | 照明器具を有する天井 |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4630115A (en) | 1983-05-09 | 1986-12-16 | The General Electric Company, P.L.C. | Cathode ray tube display device |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| WO1998039482A1 (en) | 1997-03-07 | 1998-09-11 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
| ATE533784T1 (de) | 1997-10-02 | 2011-12-15 | Altor Bioscience Corp | Lösliche, einzelkettige proteine des t- zellrezeptors |
| EP1259601A2 (en) | 2000-02-22 | 2002-11-27 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| JP2003531588A (ja) | 2000-04-11 | 2003-10-28 | ジェネンテック・インコーポレーテッド | 多価抗体とその用途 |
| IL160359A0 (en) | 2001-08-31 | 2004-07-25 | Avidex Ltd | Soluble t cell receptor |
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| ATE475669T1 (de) | 2004-06-29 | 2010-08-15 | Immunocore Ltd | Einen modifizierten t-zellen-rezeptor exprimierende zellen |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| GB0908613D0 (en) * | 2009-05-20 | 2009-06-24 | Immunocore Ltd | T Cell Reseptors |
| GB0911566D0 (en) | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| AU2013289883B2 (en) | 2012-07-13 | 2018-11-01 | Zymeworks Bc Inc. | Bispecific asymmetric heterodimers comprising anti-CD3 constructs |
| IL263466B2 (en) | 2013-12-17 | 2023-10-01 | Genentech Inc | Anti-CD3 antibodies and methods of using them |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| GB201522592D0 (en) | 2015-12-22 | 2016-02-03 | Immunocore Ltd | T cell receptors |
| SMT202200306T1 (it) | 2016-04-08 | 2022-09-14 | Immunocore Ltd | Recettori di cellule t |
| GB201709866D0 (en) | 2017-06-20 | 2017-08-02 | Immunocore Ltd | T cell receptors |
| GB201915282D0 (en) * | 2019-10-22 | 2019-12-04 | Immunocore Ltd | Specific binding molecules |
| GB202006629D0 (en) * | 2020-05-05 | 2020-06-17 | Immunocore Ltd | Specific binding molecules |
| US12103971B2 (en) * | 2022-02-20 | 2024-10-01 | Immunocore Limited | HIV specific binding molecules |
| KR20250070621A (ko) * | 2022-08-18 | 2025-05-20 | 이뮤노코어 리미티드 | Mage-a4에 특이적인 t 세포 수용체 융합 단백질 |
| WO2024146936A1 (en) * | 2023-01-06 | 2024-07-11 | Immunocore Limited | Binding molecules against a piwil1 peptide-hla complex |
| WO2024146951A1 (en) * | 2023-01-06 | 2024-07-11 | Immunocore Limited | Binding molecules against a prame peptide-hla complex |
-
2019
- 2019-01-30 GB GBGB1901305.1A patent/GB201901305D0/en not_active Ceased
-
2020
- 2020-01-30 MX MX2021009275A patent/MX2021009275A/es unknown
- 2020-01-30 BR BR112021014963-5A patent/BR112021014963A2/pt unknown
- 2020-01-30 EP EP20703192.3A patent/EP3917959A1/en active Pending
- 2020-01-30 IL IL284926A patent/IL284926B2/en unknown
- 2020-01-30 US US17/427,592 patent/US12590152B2/en active Active
- 2020-01-30 CA CA3127144A patent/CA3127144A1/en active Pending
- 2020-01-30 CN CN202080012045.4A patent/CN113728005B/zh active Active
- 2020-01-30 WO PCT/EP2020/052315 patent/WO2020157210A1/en not_active Ceased
- 2020-01-30 AU AU2020215776A patent/AU2020215776A1/en active Pending
- 2020-01-30 JP JP2021544406A patent/JP7530904B2/ja active Active
- 2020-01-30 KR KR1020217027112A patent/KR20210121141A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523507A5 (enExample) | ||
| Wang et al. | Research progress and applications of multivalent, multispecific and modified nanobodies for disease treatment | |
| JP6023172B2 (ja) | 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質 | |
| JP2023509448A5 (enExample) | ||
| IL276530A (en) | Humanized or chimeric cd3 antibodies | |
| US12098203B2 (en) | Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA | |
| JP2022548043A5 (enExample) | ||
| JP2021528973A5 (enExample) | ||
| EP2050764A1 (en) | Novel polyvalent bispecific antibody format and uses thereof | |
| JP2017529067A (ja) | Ｃｄ３結合ドメイン | |
| JP2013500703A5 (enExample) | ||
| HRP20191083T1 (hr) | Molekule antitijela za tim-3 i njihove upotrebe | |
| HRP20251181T1 (hr) | Protutijela na protein gprc5d, bispecifične molekule koje vezuju antigen i koje vezuju gprc5d i cd3 te njihove primjene | |
| TW201803899A (zh) | 三特異性和／或三價結合蛋白 | |
| CA3232364A1 (en) | Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof | |
| JP2014158485A5 (enExample) | ||
| JP2021515798A5 (enExample) | ||
| US11365240B2 (en) | Anti-HSA antibodies | |
| JP2023532129A5 (enExample) | ||
| JP2022534433A (ja) | 抗ｇａｌ９免疫阻害性結合分子 | |
| TW202204424A (zh) | 用於人類疾病之治療的ｃｄ３８抗體 | |
| JP2025506341A5 (enExample) | ||
| CN114786720A (zh) | TriAx抗体的组合物及其制备和使用方法 | |
| JP2024541476A5 (enExample) | ||
| KR20240031229A (ko) | 알파-시누클레인병증 치료용 항체 |